Advertisement

Topics

Upadacitinib a plus for AbbVie in rheumatoid arthritis, doc survey says

08:00 EDT 14 Jun 2019 | BioPharmaDive

A Piper Jaffray survey of physicians suggests the new drug won't cannibalize Humira, but instead take share from Olumiant and Xeljanz.

Original Article: Upadacitinib a plus for AbbVie in rheumatoid arthritis, doc survey says

NEXT ARTICLE

More From BioPortfolio on "Upadacitinib a plus for AbbVie in rheumatoid arthritis, doc survey says"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...